-
ARTIFICIAL INTELLIGENCE-DRIVEN CLINICAL DRUG REPORT GENERATION
Mar 18, 2026, 21:38 PM -
MANAGING LIMITATIONS OF NET PRICE ESTIMATES AT LAUNCH
Mar 18, 2026, 21:38 PM -
A FRAMEWORK FOR INCORPORATING DISTANCE-TO-CARE METRICS IN CANCER OUTCOMES RESEARCH: EXPLORATORY INSIGHTS USING REAL-WORLD DATA FROM A NETWORK OF COMMUNITY PRACTICES
Mar 18, 2026, 21:38 PM -
USING AI TO MAP HEOR EVIDENCE GAPS: FINDINGS FROM A LARGE-SCALE LLM-BASED CLASSIFICATION ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE TO SUPPORT HEALTH TECHNOLOGY ASSESSMENT AND PAYER DECISION MAKING: A REVIEW OF POLICY AND GUIDANCE ACROSS EUROPE, CANADA, AND THE UNITED STATES
Mar 18, 2026, 21:38 PM -
SUCCESSFUL USES OF REAL-WORLD EVIDENCE IN FDA LABEL UPDATES: A DESCRIPTIVE ANALYSIS OF REGULATORY TRENDS
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF EARLY PREGNANCY IDENTIFICATION AND VIRTUAL GAP CLOSURE ON HEDIS METRICS
Mar 18, 2026, 21:38 PM -
EXPLORING THE POTENTIAL IMPACT OF THE INFLATION REDUCTION ACT’S PART D REDESIGN ON FORMULARY COVERAGE?IN COMPETITIVE CLASSES: 2024-2026
Mar 18, 2026, 21:38 PM -
A NEXT-GENERATION FRAMEWORK FOR AI-AUGMENTED, SUBMISSION-GRADE LITERATURE REVIEWS: A MULTI-PROJECT ANALYSIS OF SPEED, ACCURACY, AND WORKFLOW EVOLUTION
Mar 18, 2026, 21:38 PM -
A STRUCTURED FRAMEWORK FOR CATEGORISING UNMET NEED IN HTA: APPLICATION TO SOLID TUMOR ASSESSMENTS ACROSS EIGHT OECD COUNTRIES
Mar 18, 2026, 21:38 PM -
DESCRIPTION OF THE CHARACTERISTICS AND BURDEN OF NEUROFIBROMATOSIS TYPE 1 WITH PLEXIFORM NEUROFIBROMA IN A SAMPLE OF ADULT PATIENTS IN THE USA: RESULTS FROM A REAL-WORLD SURVEY
Mar 18, 2026, 21:38 PM -
PERFORMANCE OF AI METHODS FOR TITLE/ABSTRACT SCREENING: COMPARING CRITERIA-BASED AND ADVANCEMENT PROBABILITY-BASED SCREENING APPROACHES
Mar 18, 2026, 21:38 PM -
COMPARING HEALTH, HEALTH AND WELLBEING (HWB), AND QUALITY OF LIFE (QOL) VISUAL ANALOGUE SCALE (VAS) CONSTRUCTS WITH THE EQ-HWB-9 IN THE UNITED STATES (US), UNITED KINGDOM (UK), AND GERMANY
Mar 18, 2026, 21:38 PM -
BONE MARROW BIOPSIES IN HEMATOLOGIC CANCERS: A SYSTEMATIC REVIEW OF PATIENT AND CAREGIVER BURDEN
Mar 18, 2026, 21:38 PM -
DRIVERS OF MOBILE PATIENT PORTAL APP USE: INSIGHTS FOR IMPLEMENTATION AND VALUE-BASED DECISION-MAKING
Mar 18, 2026, 21:38 PM -
ACCESS CHALLENGES IDENTIFIED BY WOMEN WITH CARDIOVASCULAR DISEASE: FINDINGS FROM THE SECOND PHASE OF THE PATIENT-LED INSIGHTS AND PATIENT EXPERIENCES WITH CARDIOVASCULAR DISEASE (IPEC2) INITIATIVE
Mar 18, 2026, 21:38 PM -
CONCOMITANT USE OF DPP4 INHIBITORS AND RAAS INHIBITORS AND RISK OF ANGIOEDEMA: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
HEALTHCARE UTILIZATION AND COSTS ATTRIBUTABLE TO CLINICALLY IMPACTFUL IMMUNE-RELATED ADVERSE EVENTS AMONG OLDER ADULTS WITH ADVANCED NON-SMALL CELL LUNG CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS
Mar 18, 2026, 21:38 PM -
THE ICEBERG STUDY: VALIDATING PATIENT RIGHT OF ACCESS DATA COLLECTION AS A NOVEL METHOD FOR LONGITUDINAL RWD GENERATION IN CLINICAL RESEARCH
Mar 18, 2026, 21:38 PM -
FDA APPROVALS OF SPECIALTY DRUGS, 2000-2024
Mar 18, 2026, 21:38 PM
